Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Clinical Immunology (Orlando, Fla.)|June 21, 2014
Targeting the IL-17/IFN-γ axis as a potential new clinical therapy for type 1 diabetesAshish K Marwaha, Sara Tan, Jan P DutzFrontiers in Immunology|June 8, 2012
TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?Ashish K Marwaha, Nicole J Leung, Alicia N McMurchy, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 3, 2010
Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetesAshish K Marwaha, Sarah Q Crome, Constadina Panagiotopoulos, et al.JCI Insight|February 8, 2019
Treg gene signatures predict and measure type 1 diabetes trajectoryAnne M Pesenacker, Virginia Chen, Jana Gillies, et al.Immunotherapy Advances|January 24, 2022
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetesAshish K Marwaha, Samuel Chow, Anne M Pesenacker, et al.The Journal of Allergy and Clinical Immunology|April 12, 2025
Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) functional deficiency caused by biallelic LRBA missense variants characterized by Evans syndrome or colitisSamuel C C Chiang, Li Yang, Erika Owsley, et al.Pageof 1